Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Journal for Immunotherapy of Cancer
|
July 9, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
Domenico Mallardo, Mario Fordellone, Michael Bailey, et al.
Oncoimmunology
|
March 28, 2017
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients
Rossana Tallerico, Costanza M Cristiani, Elina Staaf, et al.
Journal for Immunotherapy of Cancer
|
December 28, 2020
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
Roberta Turiello, Mariaelena Capone, Diana Giannarelli, et al.
Cell Reports
|
November 9, 2022
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma
Pietro Carotenuto, Alessia Romano, Anna Barbato, et al.
Cancer Immunology Research
|
April 4, 2019
Accumulation of Circulating CCR7<sup>+</sup> Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway
Costanza Maria Cristiani, Alice Turdo, Valeria Ventura, et al.
Biology
|
August 27, 2021
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression
Gabriele Madonna, Silvia Sale, Mariaelena Capone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Cancer Immunology, Immunotherapy : CII
|
October 13, 2018
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
Maria Pia Pistillo, Vincenzo Fontana, Anna Morabito, et al.
Frontiers in Immunology
|
March 14, 2018
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
Paola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Frontiers in Immunology
|
April 28, 2017
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
Paola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Journal for Immunotherapy of Cancer
|
July 9, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
Domenico Mallardo, Mario Fordellone, Michael Bailey, et al.
Oncoimmunology
|
March 28, 2017
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients
Rossana Tallerico, Costanza M Cristiani, Elina Staaf, et al.
Journal for Immunotherapy of Cancer
|
December 28, 2020
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
Roberta Turiello, Mariaelena Capone, Diana Giannarelli, et al.
Cell Reports
|
November 9, 2022
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma
Pietro Carotenuto, Alessia Romano, Anna Barbato, et al.
Cancer Immunology Research
|
April 4, 2019
Accumulation of Circulating CCR7<sup>+</sup> Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway
Costanza Maria Cristiani, Alice Turdo, Valeria Ventura, et al.
Biology
|
August 27, 2021
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression
Gabriele Madonna, Silvia Sale, Mariaelena Capone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2016
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, et al.
Cancer Immunology, Immunotherapy : CII
|
October 13, 2018
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
Maria Pia Pistillo, Vincenzo Fontana, Anna Morabito, et al.
Frontiers in Immunology
|
March 14, 2018
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
Paola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Frontiers in Immunology
|
April 28, 2017
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
Paola Queirolo, Beatrice Dozin, Anna Morabito, et al.
Page
of 7